CYTH Stock, Cyclo Therapeutics Inc. Information
Stock Information
Get CYTH Alerts
News, Short Squeeze, Breakout and More Instantly...
About Cyclo Therapeutics Inc.
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.